Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?

OBJECTIVE: To report our experiences in changing from intravitreal bevacizumab to ranibizumab in age-related macular degeneration (AMD). DESIGN: Retrospective case series. PARTICIPANTS AND METHODS: We retrospectively reviewed the records of 34 patients (36 eyes) who were treated with monthly injecti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Karagiannis, Dimitrios A, Ladas, Ioannis D, Parikakis, Efstratios, Georgalas, Ilias, Kotsolis, Athanasios, Amariotakis, Giorgos, Soumplis, Vasileios, Mitropoulos, Panagiotis
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2009
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2801585/
https://ncbi.nlm.nih.gov/pubmed/20054410
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados